DOXIPROCT PLUS
40MG/G+20MG/G+0,25MG/G RCT UNG 20G
SPC - Summary of product characteristics | |
---|---|
NR - Registration decision | |
PIL - Package leaflet | |
PAR - Public assessment report | |
Text on the wrap | |
Braills | Approved – name of the medicinal product in Braille on the packaging was confirmed. |